C

내츄럴엔도텍

168330KOSDAQ

42.5 / 100

Reference Date: 2026-10-23

Financial Score15.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 12.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Naturalendo Tech develops health supplements and cosmeceuticals using natural resources and biotechnology, focusing on anti-aging and health promotion. Through its subsidiary Endoderma, the company researches and produces micro-needle patches based on transdermal drug delivery systems (TDDS). Key products include 'Snut Wonder' for menopausal women and the 'NEEDLY' skincare line, with future goals including global market expansion and enhanced ESG practices.

Number of Employees

83people

Average Salary

49.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
2.79Industry Average 1.200.0Point

2.3x industry avg (risky)

ROE
-14.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
30.13Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲10.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -15.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 2,040Won52-week high 3,51052-week low 1,727
1-month return1.0Point

1m -12.26% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0